| Product dosage: 90mg/8mg | |||
|---|---|---|---|
| Package (num) | Per tab | Price | Buy |
| 10 | $7.03 | $70.28 (0%) | 🛒 Add to cart |
| 20 | $6.02 | $140.56 $120.48 (14%) | 🛒 Add to cart |
| 30 | $5.35 | $210.85 $160.65 (24%) | 🛒 Add to cart |
| 60 | $3.35 | $421.69 $200.81 (52%) | 🛒 Add to cart |
| 90 | $2.78 | $632.54 $250.00 (60%) | 🛒 Add to cart |
| 120 | $2.57 | $843.39 $308.24 (63%) | 🛒 Add to cart |
| 180 | $2.21 | $1265.08 $397.60 (69%) | 🛒 Add to cart |
| 270 | $2.01 | $1897.62 $542.18 (71%) | 🛒 Add to cart |
| 360 | $1.92
Best per tab | $2530.17 $690.78 (73%) | 🛒 Add to cart |
Similar products
More info:
MySimba: A Comprehensive Medical-Grade Weight Management Aid
MySimba is a prescription-only medical device designed to support sustainable weight management in adults with obesity or overweight with weight-related comorbidities. It combines advanced technology with clinically proven principles to help users achieve and maintain a healthier weight through behavior modification, reduced caloric intake, and long-term adherence support. This innovative solution represents a significant advancement in non-pharmacological weight management interventions, offering a structured, personalized approach under medical supervision. Features Combines a wearable sensor and mobile application for continuous monitoring Tracks eating pace, meal duration, and portion size through proprietary acoustic technology Provides real-time haptic feedback during meals to promote mindful eating behaviors Syncs automatically with companion mobile application via Bluetooth technology Features personalized goal setting and progress tracking functionality Includes educational content on nutrition, portion control, and behavior modification Offers healthcare provider portal for remote monitoring and support Water-resistant design suitable for daily wear Rechargeable battery with 7-day battery life CE-marked as a Class IIa medical device Benefits Supports sustainable weight loss through behavior modification rather than restrictive dieting Enhances mindfulness during eating, leading to reduced caloric intake without feelings of deprivation Provides objective data to healthcare providers for personalized treatment adjustments Promotes long-term maintenance of healthy eating habits beyond initial weight loss phase Reduces reliance on willpower alone by creating automatic eating behavior cues Offers a non-pharmacological option for weight management with minimal systemic effects Common use MySimba is primarily indicated for adults with a Body Mass Index (BMI) of ≥30 kg/m², or ≥27 kg/m² with at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea.
Abana: Natural Cardiovascular Support for Optimal Heart Health
Abana is a clinically studied, natural supplement formulated to support cardiovascular wellness and maintain healthy cholesterol levels already within the normal range. Developed through extensive research in Ayurvedic medicine, this proprietary blend combines potent botanicals and minerals known for their cardioprotective properties. Abana works holistically to promote circulatory function, support lipid metabolism, and provide antioxidant protection against oxidative stress. Its multi-mechanism approach makes it an ideal choice for individuals seeking comprehensive cardiovascular maintenance through evidence-based natural medicine.
Abhigra: Advanced Relief for Chronic Inflammatory Conditions
Abhigra represents a significant advancement in targeted anti-inflammatory therapy, engineered for patients with persistent inflammatory disorders who have found inadequate relief from conventional treatments. Developed through rigorous clinical research, this prescription medication employs a sophisticated mechanism of action to modulate inflammatory pathways at the cellular level, offering a new standard in both efficacy and tolerability. Its precision-targeted formulation minimizes systemic exposure while maximizing therapeutic impact at affected sites, making it a preferred option among rheumatologists, gastroenterologists, and dermatologists specializing in autoimmune and chronic inflammatory diseases.
Abilify: Atypical Antipsychotic for Symptom Control and Stability
Abilify (aripiprazole) is an atypical antipsychotic medication approved for the treatment of several psychiatric conditions, including schizophrenia, bipolar disorder, and as an adjunctive treatment for major depressive disorder. It functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors and as an antagonist at serotonin 5-HT2A receptors, which contributes to its unique efficacy and tolerability profile. This mechanism helps stabilize dopamine and serotonin activity in the brain, reducing symptoms such as hallucinations, delusions, and mood swings while minimizing certain side effects commonly associated with first-generation antipsychotics.
Acamprol: Clinically Proven Relief for Alcohol Dependence
Acamprol (acamprosate calcium) is a prescription medication specifically developed to support maintenance of abstinence in alcohol-dependent patients. It functions by modulating neurotransmitter systems disrupted by chronic alcohol consumption, particularly glutamatergic hyperactivity, thereby reducing the psychological distress associated with alcohol withdrawal and craving. This pharmacological agent is indicated as part of a comprehensive management program that includes psychosocial support. Its delayed-release tablet formulation ensures consistent plasma concentrations, supporting long-term therapy adherence. Clinical trials and post-marketing surveillance have established its efficacy and safety profile in diverse patient populations.
Accufine: Precision-Engineered Relief for Chronic Neuropathic Pain
Accufine represents a significant advancement in the pharmacological management of moderate to severe chronic neuropathic pain. This prescription medication, containing the active ingredient Pregabalin, is specifically formulated to modulate hyperexcited neurons, providing targeted relief where traditional analgesics often fall short. Its development is grounded in robust clinical research, offering a reliable option for clinicians seeking to improve quality of life for patients suffering from debilitating nerve pain conditions. By specifically targeting the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, Accufine reduces the release of several neurotransmitters, thereby diminishing pain signals and associated symptoms.
Accupril: Effective Blood Pressure Control for Cardiovascular Health
Accupril (quinapril hydrochloride) is an angiotensin-converting enzyme (ACE) inhibitor prescription medication specifically formulated for the management of hypertension and heart failure. As a trusted therapeutic option in cardiovascular medicine, it works by relaxing blood vessels to allow blood to flow more smoothly, thereby reducing the heart’s workload. This medication represents a cornerstone treatment in modern cardiology practice, offering both efficacy and a well-established safety profile when administered under proper medical supervision.
Accutane: The Definitive Solution for Severe Nodular Acne
Accutane (isotretinoin) is a powerful oral retinoid medication specifically formulated for the treatment of severe, recalcitrant nodular acne that has proven unresponsive to conventional therapies. As a derivative of vitamin A, it operates by dramatically reducing sebum production, altering follicular keratinization, and exerting anti-inflammatory effects. This comprehensive approach targets the fundamental pathological mechanisms of acne, offering a potential for long-term remission where other treatments have failed. Prescribed under strict medical supervision due to its significant effects and side effect profile, it represents a cornerstone therapy in dermatology for appropriate candidates.
Aceon: Advanced Blood Pressure Control with Perindopril
Aceon (perindopril erbumine) is an angiotensin-converting enzyme (ACE) inhibitor indicated for the treatment of hypertension, either as monotherapy or in combination with other antihypertensive agents. It is also approved for the reduction of cardiovascular risk in patients with stable coronary artery disease. This medication works by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, resulting in decreased vascular resistance and blood pressure. Clinical evidence supports its efficacy in improving endothelial function and reducing left ventricular hypertrophy, offering both hemodynamic and structural benefits to patients with cardiovascular conditions.